Amarin Corp Plc (AMRN)

[ziploc_1]

RMB...QUOTE..."the earlier misfolding of amyloid-beta causes the later plaque deposition. However, it is still controversially discussed whether this misfolding is the cause of Alzheimer’s disease or if it’s just an accompanying factor.”

Studies have shown that meds, which have the effect of removing amyloid plaque from the brain, have FAILED to improve AD.

The 'misfolding'(leading to plaque formation) is a symptom of AD, rather than the cause...This why, IMHO, the anti-inflammatory effects of Vascepa on the brain will be proven by the BRAVE study, when completed in January 2023...to mitigate AD, if used in the early stages of the disease...i.e. BEFORE significant deposits of plaque occur.